Smoking Treatment of Prisoners

Phase 3

Completed

• Conditions: Tobacco Use Cessation; Tobacco Use Disorder

• Registration Number: NCT00110630
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to determine the efficacy of a 10-week smoking cessation therapy combined with NicoDerm CQ for smoking cessation among female prisoners.

Detailed Description

This is a randomized controlled trial utilizing a wait-list control group to examine 10-week group therapy and nicotine replacement compared to wait-list for smoking cessation among female prisoners.

Study Timeline

• Study First Submitted QC: 2005-05-10
• Study First Submitted: 2005-05-11
• Study First Posted: 2005-05-11
• Study Start: 2005-06
• Primary Completion: 2007-09
• Study Completion: 2007-09
• Status Verified: 2008-09
• Last Update Submitted: 2017-01-11
• Last Update Posted: 2017-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 250

Inclusion Criteria

• 1. current smoker and (2) seeking group treatment to quit smoking.

Exclusion Criteria

• (1) non-english speaking, (2) housed in segregation, (3) presence of active, severe mental illness as defined by active psychosis, manic episode, or imminently suicidal/homicidal, (4) mental retardation such that they cannot provide informed consent, and (5) due to be released or transferred to another facility within the next year.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
smoking cessation

Trial Locations

Locations (1)

Virginia Commonwealth University; 🇺🇸 Richmond, Virginia, United States